We found that inhibition of two well studied oncogenic pathways (MEK1/2 and PLK1 axes) in breast cancer significantly reduced outgrowth of basal‐like syngeneic and human breast tumors xenografts in preclinical models. This evidence concerns the gene PLK1 and breast neoplasm.